Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Recurrence
×
cemiplimab
×
Clear all
Filters
3
NCT02651662
2026-02-02
CLIO-1
Regeneron Pharmaceuticals
Phase 1
Active not recruiting
105 enrolled
NCT06022029
2025-12-24
ON-5001
OncoNano Medicine, Inc.
Phase 1
Recruiting
168 enrolled